Rankings
▼
Calendar
SGHT Q4 2023 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena
SGHT
Sight Sciences, Inc.
$224M
Q4 2023 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$19M
-8.7% YoY
Gross Profit
$16M
85.2% margin
Operating Income
-$11M
-59.3% margin
Net Income
-$11M
-57.0% margin
EPS (Diluted)
$-0.22
QoQ Revenue Growth
-6.3%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$7M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$167M
Total Liabilities
$46M
Stockholders' Equity
$120M
Cash & Equivalents
$138M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$19M
$21M
-8.7%
Gross Profit
$16M
$17M
-5.4%
Operating Income
-$11M
-$17M
+34.9%
Net Income
-$11M
-$17M
+36.8%
Revenue Segments
Surgical Glaucoma
$17M
87%
Dry Eye
$3M
13%
← FY 2023
All Quarters
Q1 2024 →